Ken Griffin Sunshine Biopharma Inc Wt Exp Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sunshine Biopharma Inc Wt Exp stock. As of the latest transaction made, Citadel Advisors LLC holds 45,131 shares of SBFMW stock, worth $5,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,131
Previous 68,370 33.99%
Holding current value
$5,415
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.05 - $0.24 $1,161 - $5,577
-23,239 Reduced 33.99%
45,131 $4,000
Q2 2024

Aug 14, 2024
BUY
$0.05 - $0.18 $62 - $225
1,255 Added 1.87%
68,370 $4,000
Q1 2024

May 15, 2024
BUY
$0.04 - $0.3 $219 - $1,645
5,485 Added 8.9%
67,115 $3,000
Q4 2023

Feb 14, 2024
SELL
$0.12 - $0.29 $507 - $1,225
-4,226 Reduced 6.42%
61,630 $12,000
Q3 2023

Nov 14, 2023
BUY
$0.17 - $0.5 $5,900 - $17,354
34,708 Added 111.43%
65,856 $14,000
Q2 2023

Aug 14, 2023
BUY
$0.31 - $0.68 $9,655 - $21,180
31,148 New
31,148 $11,000

Others Institutions Holding SBFMW

# of Institutions
4
Shares Held
62K
Call Options Held
0
Put Options Held
0
View Full List

About SUNSHINE BIOPHARMA INC WT EXP

SBFMW Quotes by TradingView
  • Ticker SBFMW
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
More about SBFMW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email